§ Funding Round
Series B funding round for Kyverna Therapeutics raising $85M in January 2022
Series B funding round for Kyverna Therapeutics raising $85M in January 2022
| Investor | Firm Type | Partner |
|---|---|---|
Access Biotechnology | — | — |
| Organization | — | |
| Organization | — | |
Westlake Village BioPartners | — | — |
| Angel | sean harper | |
| Organization | — | |
| Organization | — | |
| Angel | mark genovese | |
HealthCor | — | — |
| Organization | — | |
| Organization | — | |
Intellia Therapeutics | — | — |
| Organization | — | |
| Organization | — | |
Niu (Chris) Liu | — | — |
| Angel | fred cohen |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$170M
Top Valuation
-
Kyverna Therapeutics raised $85M in a Series B round.
The round was announced on 01/01/22.
The round was led by Northpond Ventures.
